72 related articles for article (PubMed ID: 36409444)
1. Value of exhaled hydrogen sulfide in early diagnosis of esophagogastric junction adenocarcinoma.
Liu F; Wei L; Zheng B; Su X; Ju J; Liu G; Liu Q
Oncol Lett; 2024 Jul; 28(1):321. PubMed ID: 38807679
[TBL] [Abstract][Full Text] [Related]
2. Multiomics combined with single-cell analysis shows that mitophagy-related genes could accurately predict the prognosis of patients with clear cell renal cell carcinoma.
Yin H; Xiao Y; Li H; Wang Y; Zhang L; Yao A; Kang S; Cao F
Transl Cancer Res; 2024 Feb; 13(2):819-832. PubMed ID: 38482447
[TBL] [Abstract][Full Text] [Related]
3. BNIPL is a promising biomarker of laryngeal cancer: novel insights from bioinformatics analysis and experimental validation.
Wang R; Gao Y; Wen S; Guo X
BMC Med Genomics; 2024 Feb; 17(1):45. PubMed ID: 38302910
[TBL] [Abstract][Full Text] [Related]
4. Diabetes Mellitus and Gastric Cancer: Correlation and Potential Mechanisms.
Wang L; Zhang Z
J Diabetes Res; 2023; 2023():4388437. PubMed ID: 38020199
[TBL] [Abstract][Full Text] [Related]
5. Blood-based Markers in the Prognostic Prediction of Esophagogastric Junction Cancer.
Liu CT; Hong CQ; Huang XC; Li EM; Xu YW; Peng YH
J Cancer; 2020; 11(15):4332-4342. PubMed ID: 32489452
[TBL] [Abstract][Full Text] [Related]
6. Serum insulin-like growth factor binding protein 3 as a promising diagnostic and prognostic biomarker in esophagogastric junction adenocarcinoma.
Ding TY; Peng YH; Hong CQ; Huang BL; Liu CT; Luo Y; Chu LY; Zhang B; Li XH; Qu QQ; Xu YW; Wu FC
Discov Oncol; 2022 Nov; 13(1):128. PubMed ID: 36409444
[TBL] [Abstract][Full Text] [Related]
7. Serum insulin-like growth factor binding protein-3 as a potential biomarker for diagnosis and prognosis of oesophageal squamous cell carcinoma.
Luo Y; Hong CQ; Huang BL; Ding TY; Chu LY; Zhang B; Qu QQ; Li XH; Liu CT; Peng YH; Guo HP; Xu YW
Ann Med; 2022 Dec; 54(1):2153-2166. PubMed ID: 35930383
[TBL] [Abstract][Full Text] [Related]
8. Serum Insulin-Like Growth Factor Binding Protein 7 as a Potential Biomarker in the Diagnosis and Prognosis of Esophagogastric Junction Adenocarcinoma.
Liu CT; Xu YW; Guo H; Hong CQ; Huang XY; Luo YH; Yang SH; Chu LY; Li EM; Peng YH
Gut Liver; 2020 Nov; 14(6):727-734. PubMed ID: 31822054
[TBL] [Abstract][Full Text] [Related]
9. Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma.
Xu YW; Chen H; Guo HP; Yang SH; Luo YH; Liu CT; Huang XY; Tang XM; Hong CQ; Li EM; Xu LY; Peng YH
Gastric Cancer; 2019 May; 22(3):546-557. PubMed ID: 30426295
[TBL] [Abstract][Full Text] [Related]
10. Serum DSG2 as a potential biomarker for diagnosis of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma.
Liu YQ; Chu LY; Yang T; Zhang B; Zheng ZT; Xie JJ; Xu YW; Fang WK
Biosci Rep; 2022 May; 42(5):. PubMed ID: 35521959
[TBL] [Abstract][Full Text] [Related]
11. The Early Diagnostic Value of Serum Interleukin-8 in Esophagogastric Junction Adenocarcinoma.
Li Z; Xu H; Yu J; Liu C; Zheng C; Zeng R; Xu L; Li E; Peng Y; Xu Y
Cancer Control; 2021; 28():10732748211004883. PubMed ID: 33926265
[TBL] [Abstract][Full Text] [Related]
12. Association of IGF-1 and IGFBP-3 levels with gastric cancer: A systematic review and meta-analysis.
Liu H; Gu H; Kutbi EH; Tan SC; Low TY; Zhang C
Int J Clin Pract; 2021 Nov; 75(11):e14764. PubMed ID: 34469629
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor binding protein 3 promotes radiosensitivity of oral squamous cell carcinoma cells via positive feedback on NF-κB/IL-6/ROS signaling.
Wang SH; Chen YL; Hsiao JR; Tsai FY; Jiang SS; Lee AY; Tsai HJ; Chen YW
J Exp Clin Cancer Res; 2021 Mar; 40(1):95. PubMed ID: 33712045
[TBL] [Abstract][Full Text] [Related]
14. Patterns of recurrence in adenocarcinoma of the esophagogastric junction: a retrospective study.
Xu H; Zhang L; Miao J; Liu S; Liu H; Jia T; Zhang Q
World J Surg Oncol; 2020 Jun; 18(1):144. PubMed ID: 32593312
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
